Phase 3 Marketing and Communications Revenue and Competitors
Estimated Revenue & Valuation
- Phase 3 Marketing and Communications's estimated annual revenue is currently $34.5M per year.
- Phase 3 Marketing and Communications's estimated revenue per employee is $250,000
Employee Data
- Phase 3 Marketing and Communications has 138 Employees.
- Phase 3 Marketing and Communications grew their employee count by 1% last year.
Phase 3 Marketing and Communications's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Co-Founder and CIO | Reveal Email/Phone |
3 | Co-Founder & President | Reveal Email/Phone |
4 | Sr VP / General Manager | Reveal Email/Phone |
5 | SVP, Digital Programming & Development | Reveal Email/Phone |
6 | VP, Operations | Reveal Email/Phone |
7 | SVP, Sales | Reveal Email/Phone |
8 | VP, Sales | Reveal Email/Phone |
9 | VP Sales | Reveal Email/Phone |
10 | SVP, PR and Client Engagement | Reveal Email/Phone |
Phase 3 Marketing and Communications Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.8M | 49 | 11% | N/A | N/A |
#2 | $21.3M | 85 | 23% | N/A | N/A |
#3 | $15M | 94 | -10% | N/A | N/A |
#4 | $16.9M | 75 | 14% | N/A | N/A |
#5 | $3.5M | 72 | 177% | N/A | N/A |
#6 | $0.5M | 4 | 0% | N/A | N/A |
#7 | $16.7M | 74 | -16% | N/A | N/A |
#8 | $156.6M | 501 | N/A | N/A | N/A |
#9 | $16.9M | 75 | 4% | N/A | N/A |
#10 | $1.7M | 11 | -15% | N/A | N/A |
What Is Phase 3 Marketing and Communications?
Nestled within Atlanta’s Fairlie-Poplar District between Fairlie and Forsyth Street, our downtown Atlanta offices boast historic charm and a recently renovated interior. The site is adjacent to the Georgia State Campus and walking distance to CNN Center and Centennial Olympic Park.
keywords:N/A
N/A
Total Funding
138
Number of Employees
$34.5M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Phase 3 Marketing and Communications News
BeiGene Presents Updated Results from Phase 3 RATIONALE-309 Trial of PD-1 ... and marketing of tislelizumab in the U.S., Europe and Japan.
We then proceeded to this phase 3 study of single-agent plinabulin ... the FDA was not convinced to approve marketing of plinabulin in the...
Updated Phase 3 SIERRA data to be presented in an oral presentation ... acceptable as the basis for a Marketing Authorization Application.
Other Companies in Vinings
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $750M | 146 | 0% | N/A |
#2 | $44.6M | 150 | 11% | N/A |
#3 | $21M | 154 | N/A | N/A |
#4 | $15M | 157 | -3% | N/A |
#5 | $26M | 161 | -9% | $6M |